Ganaxolone: Phase II data

Top-line data from a double-blind, crossover, U.S. and Belgian Phase II trial in 59 patients ages 6-17 with Fragile X syndrome showed

Read the full 223 word article

How to gain access

Continue reading with a
two-week free trial.